Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side Effect Concerta Augmentin
DRUG INEFFECTIVE 5.3% 1.6%
DRUG HYPERSENSITIVITY 0% 4%
DIARRHOEA 0.8% 3.5%
PYREXIA 0.8% 3%
HEADACHE 2.9% 1.6%
NAUSEA 2.4% 2.7%
DYSPNOEA 1% 2.7%
FATIGUE 2.2% 2.3%
VOMITING 1.7% 2.3%
ANXIETY 2.3% 1.2%
DEPRESSION 2.3% 0.8%
INSOMNIA 2.3% 0.8%
RASH 0.8% 2.2%
AGGRESSION 2.1% 0%
OFF LABEL USE 2% 0.8%
PNEUMONIA 0% 2%
SUICIDAL IDEATION 2% 0%
PAIN 1.1% 1.9%
PRURITUS 0.7% 1.9%
DRUG DOSE OMISSION 1.9% 0%
DECREASED APPETITE 1.8% 0.9%
ABNORMAL BEHAVIOUR 1.8% 0%
ASTHENIA 0.7% 1.7%
DISTURBANCE IN ATTENTION 1.7% 0%
DIZZINESS 1.6% 1.3%
WEIGHT DECREASED 1.6% 1.1%
FEELING ABNORMAL 1.6% 0.5%
ANAEMIA 0% 1.6%
MALAISE 1.1% 1.5%
SOMNOLENCE 1.5% 0.6%
AGITATION 1.5% 0%
WEIGHT INCREASED 1.5% 0%
ABDOMINAL PAIN 0.8% 1.3%
PRODUCT SUBSTITUTION ISSUE 1.3% 0%
SINUSITIS 0% 1.3%
ERYTHEMA 0% 1.3%
HYPOTENSION 0% 1.3%
DRUG INTERACTION 0.9% 1.2%
HYPERTENSION 1.2% 0.8%
TACHYCARDIA 1.2% 0.5%
COUGH 0.5% 1.2%
SUICIDE ATTEMPT 1.2% 0%
ACUTE KIDNEY INJURY 0% 1.2%
IRRITABILITY 1.2% 0%
THROMBOCYTOPENIA 0% 1.1%
TREMOR 1.1% 0%
FALL 0.6% 1%
OVERDOSE 1% 0.5%
ARTHRALGIA 0.5% 1%
HALLUCINATION 1% 0%
PRODUCT USE ISSUE 1% 0%
CHOLESTASIS 0% 1%
RENAL FAILURE ACUTE 0% 1%
DEATH 0% 1%
DRUG EFFECT DECREASED 1% 0%
DEHYDRATION 0% 1%
URTICARIA 0% 1%
CHEST PAIN 0.9% 0.9%
ABDOMINAL PAIN UPPER 0.8% 0.9%
CONDITION AGGRAVATED 0.9% 0.8%
CONFUSIONAL STATE 0.7% 0.9%
PAIN IN EXTREMITY 0.5% 0.9%
BACK PAIN 0.5% 0.9%
RENAL FAILURE 0% 0.9%
NEUTROPENIA 0% 0.9%
URINARY TRACT INFECTION 0% 0.9%
OEDEMA PERIPHERAL 0% 0.9%
HEPATOCELLULAR INJURY 0% 0.9%
TIC 0.9% 0%
PALPITATIONS 0.9% 0%
HEART RATE INCREASED 0.9% 0%
PSYCHOTIC DISORDER 0.9% 0%
HYPERSENSITIVITY 0.4% 0.8%
CONSTIPATION 0.4% 0.8%
GENERAL PHYSICAL HEALTH DETERIORATION 0% 0.8%
PULMONARY EMBOLISM 0% 0.8%
SEPSIS 0% 0.8%
JAUNDICE 0% 0.8%
TOXICITY TO VARIOUS AGENTS 0.8% 0%
BRONCHITIS 0% 0.8%
GYNAECOMASTIA 0.8% 0%
PSYCHOMOTOR HYPERACTIVITY 0.8% 0%
ANGER 0.8% 0%
RASH MACULO-PAPULAR 0% 0.8%
HYPERHIDROSIS 0.7% 0.5%
INJURY 0% 0.7%
DEEP VEIN THROMBOSIS 0% 0.7%
ATRIAL FIBRILLATION 0% 0.7%
CHILLS 0% 0.7%
PANCYTOPENIA 0% 0.7%
HOSPITALISATION 0.7% 0%
BLOOD PRESSURE INCREASED 0.7% 0%
DYSKINESIA 0.7% 0%
ADVERSE EVENT 0.7% 0%
GROWTH RETARDATION 0.7% 0%
INCORRECT DOSE ADMINISTERED 0.7% 0%
LOSS OF CONSCIOUSNESS 0.6% 0.5%
CRYING 0.6% 0%
CONVULSION 0.6% 0%
SYNCOPE 0.6% 0%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 0.6% 0%
SLEEP DISORDER 0.6% 0%
MYALGIA 0% 0.6%
HEPATITIS 0% 0.6%
RESPIRATORY FAILURE 0% 0.6%
ASPARTATE AMINOTRANSFERASE INCREASED 0% 0.6%
INTERNATIONAL NORMALISED RATIO INCREASED 0% 0.6%
RESTLESSNESS 0.6% 0%
VISION BLURRED 0.6% 0%
INFECTION 0% 0.6%
NEUROPATHY PERIPHERAL 0% 0.6%
CELLULITIS 0% 0.6%
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 0% 0.6%
ALANINE AMINOTRANSFERASE INCREASED 0% 0.6%
DRUG ABUSE 0.6% 0%
PRODUCT QUALITY ISSUE 0.6% 0%
MOOD SWINGS 0.6% 0%
TREATMENT NONCOMPLIANCE 0.6% 0%
HYPOAESTHESIA 0.5% 0.5%
MUSCLE SPASMS 0.5% 0.5%
PARAESTHESIA 0.5% 0.5%
EPISTAXIS 0% 0.5%
FEBRILE NEUTROPENIA 0% 0.5%
LEUKOPENIA 0% 0.5%
TOXIC SKIN ERUPTION 0% 0.5%
UPPER RESPIRATORY TRACT INFECTION 0% 0.5%
HEPATITIS CHOLESTATIC 0% 0.5%
CARDIAC ARREST 0% 0.5%
TOXIC EPIDERMAL NECROLYSIS 0% 0.5%
ANAPHYLACTIC REACTION 0% 0.5%
CARDIAC FAILURE 0% 0.5%
DYSPHAGIA 0% 0.5%
EOSINOPHILIA 0% 0.5%
BLOOD ALKALINE PHOSPHATASE INCREASED 0% 0.5%
EMOTIONAL DISTRESS 0% 0.5%
GAIT DISTURBANCE 0% 0.5%
AGRANULOCYTOSIS 0% 0.5%
PLEURAL EFFUSION 0% 0.5%
COMPLETED SUICIDE 0.5% 0%
HAEMOGLOBIN DECREASED 0% 0.5%
INTENTIONAL OVERDOSE 0.5% 0%
HALLUCINATION, AUDITORY 0.5% 0%
MEMORY IMPAIRMENT 0.5% 0%
EMOTIONAL DISORDER 0.5% 0%
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 0.5% 0%
DEPRESSED MOOD 0.5% 0%
MIGRAINE 0.5% 0%
HALLUCINATION, VISUAL 0.5% 0%
ATTENTION DEFICIT/HYPERACTIVITY DISORDER 0.5% 0%
SPEECH DISORDER 0.4% 0%
NASOPHARYNGITIS 0.4% 0%
DYSTONIA 0.4% 0%
PRODUCT USE IN UNAPPROVED INDICATION 0.4% 0%
UNEVALUABLE EVENT 0.4% 0%
DRY MOUTH 0.4% 0%
NERVOUSNESS 0.4% 0%
MOOD ALTERED 0.4% 0%

New treatments are found every day. View current Concerta research studies and Augmentin clinical trials

1